Wall Street Zen cut shares of American Vanguard (NYSE:AVD – Free Report) from a hold rating to a sell rating in a report issued on Saturday.
Separately, Weiss Ratings downgraded shares of American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.
Check Out Our Latest Report on American Vanguard
American Vanguard Price Performance
American Vanguard (NYSE:AVD – Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The basic materials company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.43). The company had revenue of $116.75 million during the quarter, compared to analyst estimates of $135.00 million. American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.
Institutional Trading of American Vanguard
Hedge funds and other institutional investors have recently modified their holdings of the company. Bank of America Corp DE acquired a new stake in shares of American Vanguard in the second quarter valued at $79,000. Hsbc Holdings PLC acquired a new position in American Vanguard during the second quarter worth about $193,000. Algert Global LLC acquired a new position in American Vanguard during the second quarter worth about $123,000. Ieq Capital LLC bought a new stake in American Vanguard in the second quarter worth about $117,000. Finally, BlackRock Inc. bought a new stake in American Vanguard in the second quarter worth about $2,614,000. Institutional investors own 79.00% of the company’s stock.
About American Vanguard
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Read More
- Five stocks we like better than American Vanguard
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.
